Page last updated: 2024-10-30

metformin and Idiopathic Inflammatory Myopathies

metformin has been researched along with Idiopathic Inflammatory Myopathies in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Khalafani, Z1
Zamani-Garmsiri, F1
Panahi, G1
Meshkani, R1
Joya-Galeana, J1
Fernandez, M1
Cervera, A1
Reyna, S1
Ghosh, S1
Triplitt, C1
Musi, N1
DeFronzo, RA1
Cersosimo, E1

Trials

1 trial available for metformin and Idiopathic Inflammatory Myopathies

ArticleYear
Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.
    Diabetes/metabolism research and reviews, 2011, Volume: 27, Issue:4

    Topics: Adult; Body Mass Index; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabet

2011

Other Studies

1 other study available for metformin and Idiopathic Inflammatory Myopathies

ArticleYear
Metformin-chlorogenic acid combination reduces skeletal muscle inflammation in c57BL/6 mice on high-fat diets.
    Molecular biology reports, 2023, Volume: 50, Issue:3

    Topics: Adipose Tissue; Animals; Chlorogenic Acid; Diet, High-Fat; Inflammation; Insulin Resistance; Metform

2023